Fusion event
HBV-chr21 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Region type
precore/core protein|Core and e antigen|
Integrated sequence
ATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGCTGTGCCTTGGGTGGCTTTGGGGCATGGACATCGACC| |CTTATAAAGAATTTGGAGCTACTGTGGAGTTACTCTCGTTTTTGCCTTCTGACTTCTTTCCTTCAGTACGAGATCTTCTAGATACCGCCTCAGCTCTGTA
End
48119844/46699932 (Hg38)
Nearest miRNA
hsa-let-7c/Upstream/1221606;
Upstream sequence
tactcatggagggtgagggtgagggtgagggtgagggttaggggttagggttagggttagggttagggttagggttagggttagggttagggttagggtt
Downstream sequence
agggttagggttagggttagggttgggttagggttagggttagggttagggNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNNN
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.